首页 | 本学科首页   官方微博 | 高级检索  
     


CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group
Authors:Hidemasa Matsuo MS  MLSCM  Naomi Nakamura MS  Daisuke Tomizawa MD  PhD  Akiko Moriya Saito MD  PhD  Nobutaka Kiyokawa MD  PhD  Keizo Horibe MD  PhD  Yoko Nishinaka‐Arai MS  PhD  Mayu Tokumasu MD  PhD  Hiroshi Itoh MS  PhD  Yasuhiko Kamikubo MD  PhD  Hideki Nakayama MD  PhD  Akitoshi Kinoshita MD  PhD  Takashi Taga MD  PhD  Akio Tawa MD  PhD  Tomohiko Taki MD  PhD  Shiro Tanaka PhD  Souichi Adachi MD  PhD
Affiliation:1. Department of Human Health Sciences, Kyoto University, Kyoto, Japan;2. Department of Clinical Laboratory, Kyoto University Hospital, Kyoto, Japan;3. Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan;4. Clinical Research Center, National Nagoya Hospital, Aichi, Japan;5. Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan;6. Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan;7. Department of Pediatrics, Kyoto University, Kyoto, Japan;8. Department of Pediatrics, National Hospital Organization, Fukuoka‐Higashi Medical Center, Fukuoka, Japan;9. Department of Pediatrics, St. Marianna University School of Medicine, Kanagawa, Japan;10. Department of Pediatrics, Shiga University of Medical Science, Shiga, Japan;11. Department of Pediatrics, Osaka National Hospital, Osaka, Japan;12. Department of Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine, Kyoto, Japan;13. Department of Pharmacoepidemiology, Kyoto University, Kyoto, Japan
Abstract:
Keywords:CXCR4  KIT  pediatric acute myeloid leukemia  prognostic factor, t(8  21)
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号